Stock screenerAll disclosures →
EDGAR →
PGEN
Conviction 97HealthcareScan · Fri, Jun 26, 2026PGEN$5.86+6.16%
ResistanceSupportVol 14Insider sell5
Vol MA14 5.8M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price5.86
Change+6.16%
Gap-0.45%
Rel volume1.85×
Avg volume5.92M
Avg $ vol27.17M
SMA 204.52
SMA 504.31
SMA 2004.05
Price vs 50+35.90%
Price vs 200+44.61%
MA stackbullish
50/200 cross—
Supertrendup · 4.73
RSI (14)77
MACD hist0.16
MACD crossbull · 9d
Stoch %K / %D96 / 93
ADX (14)31
+DI / −DI40 / 11
RSI divergence—
MACD divergence—
ATR %+5.41%
ADR %6.87%
52w high5.86
52w low1.42
From 52w high+0.00%
Above 52w low+312.68%
New 52w highYes
SqueezeOff
Bollinger width61.65%
%B0.98
Donchian pos96.31%
Donchian high5.95
Donchian low3.51
AVWAP (52w high)5.77
vs AVWAP high+1.59%
AVWAP (52w low)3.75
vs AVWAP low+56.11%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d1.85×
Avg vol (14d)5.8M
Avg vol (20d)5.92M
Avg $ vol (20d)27.17M
Market cap—
RS 3m (vs SPY)+66.27%
RS 6m (vs SPY)+18.80%
RS line new highYes
Trend template8/8
Technical rank93.1
1 week+21.58%
1 month+33.18%
3 months+50.64%
6 months+43.98%
1 year+312.68%
YTD+36.92%
P/E-7.88
P/B97.61
P/S203.95
P/FCF-21.99
EPS-1.37
Div yield—
ROE—
ROA-180.80%
Debt/Eq6.76
Current4.82
EV/EBITDA-19.61
Gross margin—
Net margin—
Rev growth146.73%
EPS growth-98.55%
Price target12.50
Target upside125.63%
Analyst ratingBuy
Institutional40.50%
Ent. value2.1B
Revenue23.25M
Net income-7.93M
Gross profit—
Free cash flow-89.83M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees47
ListedThu, Aug 8, 2013
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction97 / 100
Pattern quality—
Tech rank93.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.77
Support3.73
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PGEN
No recent disclosed trades by Congress in PGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PGEN · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Thomasian Harry Jr. Chief Financial Officer · Common Stock · 2026-05-28 | Sell | 41.88K | $183K | 2026-05-28 | 2026-06-01 |
Shah Rutul R Chief Operating Officer · Common Stock · 2026-05-28 | Sell | 42.7K | $186K | 2026-05-28 | 2026-06-01 |
Sabzevari Helen President and CEO · Common Stock · 2026-05-28 | Sell | 119.25K | $520K | 2026-05-28 | 2026-06-01 |
Lehr Donald P. Chief Legal Officer · Common Stock · 2026-05-28 | Sell | 29.13K | $127K | 2026-05-28 | 2026-06-01 |
Tennant Phil Chief Commercial Officer · Common Stock · 2026-05-28 | Sell | 30.27K | $132K | 2026-05-28 | 2026-06-01 |
Lehr Donald P. Chief Legal Officer · Common Stock · 2026-05-23 | Exercise | 62.5K | — | 2026-05-23 | 2026-05-27 |
Lehr Donald P. Chief Legal Officer · Restricted Stock Units · 2026-05-23 | Exercise | 62.5K | $0 | 2026-05-23 | 2026-05-27 |
Tennant Phil Chief Commercial Officer · Restricted Stock Units · 2026-05-23 | Exercise | 62.5K | $0 | 2026-05-23 | 2026-05-27 |
Sabzevari Helen President and CEO · Restricted Stock Units · 2026-05-23 | Exercise | 250K | $0 | 2026-05-23 | 2026-05-27 |
Shah Rutul R Chief Operating Officer · Common Stock · 2026-05-23 | Exercise | 90K | — | 2026-05-23 | 2026-05-27 |
SEC filings
EDGAR filings in PGEN · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.